| Trial ID: | L0154 |
| Source ID: | NCT03526445
|
| Associated Drug: |
Glucagon
|
| Title: |
Hepatic Metabolic Changes in Response to Glucagon Infusion
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease|Total Pancreatectomy|Diabetes Mellitus
|
| Interventions: |
Drug: Glucagon|Drug: Saline
|
| Outcome Measures: |
Hepatic lipid metabolism|Changes in plasma concentration of lipids|Changes in plasma concentration of amino acids|Changes in plasma concentration of fibroblast growth factor 21 (FGF-21)|Endogenous glucose production|Changes in resting energy expenditure and oxidation rate|Food intake|Changes in appetite sensation
|
| Sponsor/Collaborators: |
Steno Diabetes Center Copenhagen|University of Copenhagen
|
| Gender: |
All
|
| Age: |
30 Years to 80 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
27
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science
|
| Start Date: |
May 1, 2018
|
| Completion Date: |
June 12, 2019
|
| Results First Posted: |
--
|
| Last Update Posted: |
August 6, 2019
|
| Locations: |
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
|
| URL: |
https://ClinicalTrials.gov/show/NCT03526445
|
